Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis

被引:23
作者
Fajac, I
Hubert, D
Bienvenu, T
Richaud-Thiriez, B
Matran, R
Kaplan, JC
Dall'Ava-Santucci, J
Dusser, DJ
机构
[1] Univ Paris 05, Dept Resp Physiol, Paris, France
[2] Univ Paris 05, Dept Resp Med, Paris, France
[3] Univ Paris 05, Dept Biochem Genet, Cochin Hosp, Paris, France
关键词
cystic fibrosis; nasal potential difference;
D O I
10.1183/09031936.98.12061295
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This study investigated the relations between nasal transepithelial electric potential difference (PD) and the phenotype and genotype of cystic fibrosis (CF) adult patients. Basal nasal PD was measured in 95 adult CF patients who were classified into three groups of nasal PD (expressed as absolute values) according to the 10th and the 90th percentiles (28.3 and 49.2 mV, respectively), which defined group 1 (nasal PD less than or equal to 28.3 mV), group 2 (nasal PD 28.3-49.2 mV) and group 3 (nasal PD greater than or equal to 49.2 mV), Patients from group 1 had a higher forced vital capacity (FVC) than patients from groups 2 and 3 (76.5+/-22.4 versus 57.4+/-21.2 and 55.7+/-21.1% predicted, respectively, p<0.05) and a higher forced expiratory volume in one second (FEV1) (69.3+/-24.0 versus 42.5+/-22.4 and 42.2+/-21.4% pred, respectively, p<0.01),Among patients with severe mutations (Delta F508 homozygote, or one Delta F508 mutation plus another "severe" mutation, or two "severe" mutations), patients from group 1 had a higher FVC, FEV1 and arterial oxygen tension than patients from groups 2 and 3 (p<0.05 for each comparison). The results show that in adult cystic fibrosis patients a normal basal nasal potential difference is related to milder respiratory disease, irrespective of the severity of the genotype.
引用
收藏
页码:1295 / 1300
页数:6
相关论文
共 26 条
[1]  
ALTON EWFW, 1990, EUR RESPIR J, V3, P922
[2]   MUTATION HETEROGENEITY OF CYSTIC-FIBROSIS IN FRANCE - SCREENING BY DENATURING GRADIENT GEL-ELECTROPHORESIS USING PSORALEN-MODIFIED OLIGONUCLEOTIDE [J].
BIENVENU, T ;
CAZENEUVE, C ;
KAPLAN, JC ;
BELDJORD, C .
HUMAN MUTATION, 1995, 6 (01) :23-29
[3]   HUMAN AIRWAY ION-TRANSPORT .1. [J].
BOUCHER, RC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :271-281
[4]  
CHILLON M, 1995, AM J HUM GENET, V56, P623
[5]   CFTR AND DIFFERENTIATION MARKERS EXPRESSION IN NON-CF AND DELTA-F-508 HOMOZYGOUS CF NASAL EPITHELIUM [J].
DUPUIT, F ;
KALIN, N ;
BREZILLON, S ;
HINNRASKY, J ;
TUMMLER, B ;
PUCHELLE, E .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1601-1611
[6]  
DURIE PR, 1995, PEDIAT PULMONOL, V12, P202
[7]   MOLECULAR CHARACTERIZATION OF CYSTIC-FIBROSIS - 16 NOVEL MUTATIONS IDENTIFIED BY ANALYSIS OF THE WHOLE CYSTIC-FIBROSIS CONDUCTANCE TRANSMEMBRANE REGULATOR (CFTR) CODING REGIONS AND SPLICE SITE JUNCTIONS [J].
FANEN, P ;
GHANEM, N ;
VIDAUD, M ;
BESMOND, C ;
MARTIN, J ;
COSTES, B ;
PLASSA, F ;
GOOSSENS, M .
GENOMICS, 1992, 13 (03) :770-776
[9]   A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS [J].
HIGHSMITH, WE ;
BURCH, LH ;
ZHOU, ZQ ;
OLSEN, JC ;
BOAT, TE ;
SPOCK, A ;
GORVOY, JD ;
QUITTELL, L ;
FRIEDMAN, KJ ;
SILVERMAN, LM ;
BOUCHER, RC ;
KNOWLES, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) :974-980
[10]   Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis [J].
Ho, LP ;
Samways, JM ;
Porteous, DJ ;
Dorin, DJ ;
Carothers, A ;
Greening, AP ;
Innes, JA .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (09) :2018-2022